Component: (Network and Table) | |
---|---|
Network | 0006 - Statement - Statements of Cash Flows (http://accelr8.com/role/StatementsOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0000727207 (http://www.sec.gov/CIK) |
Statement of Cash Flows [Abstract] | Period [Axis] | |
---|---|---|
2011-08-01 - 2012-07-31 | 2010-08-01 - 2011-07-31 | |
Statement of Cash Flows [Abstract] | ||
Cash flows from operating activities: | ||
Net loss | (5,310,476) | (378,761) |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||
Depreciation | 2,097 | 2,396 |
Amortization | 203,460 | 253,499 |
Equity based compensation | 781,998 | 90,021 |
Other expense, impairment loss | 1,996,583 | xsi:nil |
Unrealized gain on investments | (23,987) | (14,572) |
Realized (gain) loss on sale of investments, interest and dividends reinvested | (7,944) | (6,413) |
(Increase) decrease in assets: | ||
Accounts receivable | 590,621 | 411,477 |
Inventory | 20,015 | 2,342 |
Prepaid expense and other | 2,649 | (1,182) |
Increase (decrease) in liabilities: | ||
Accounts payable | 28,068 | 2,826 |
Accrued liabilities | 718,760 | 1,291 |
Deferred revenue | 75,548 | (10,428) |
Deferred compensation | 106,936 | 95,985 |
Net cash (used in) provided by operating activities | (815,672) | 448,481 |
Cash flows from investing activities: | ||
Purchase of equipment and patent costs | (95,505) | (75,336) |
Contribution to deferred compensation trust | (150,000) | (75,000) |
Net cash used in investing activities | (245,505) | (150,336) |
Cash flows from financing activities | ||
Exercise of Warrants and Options | 128,569 | 194,438 |
Issuance of Common Stock and warrants | 14,420,000 | xsi:nil |
Net cash provided by financing activities | 14,548,569 | 194,438 |
Increase (decrease) in cash and cash equivalents | 13,487,392 | 492,583 |
Cash and cash equivalents, beginning of year | 775,856 | 283,273 |
Cash and cash equivalents, end of year | 14,263,248 | 775,856 |